Lotemax (loteprednol etabonate) is a new topical antiinflammatory for ophthalmic use.

Treatment with Lotemax 0.5% eye drops is indicated for postoperative inflammation following ocular surgery.

One to two drops are used four times daily beginning 24 hours after surgery, continuing for up to two weeks throughout the post-operative period.

View Lotemax drug record

Further information: Bausch & Lomb

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more